![Edward Dulac](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Edward Dulac
Finanzdirektor/CFO bei
INTELLIA THERAPEUTICS, INC.
Vermögen: 2 Mio $ am 31.05.2026
Profil
Derzeit bekleidet Edward J. Dulac die Position des Chief Financial Officer & Accounting Officer bei Fate Therapeutics, Inc. In der Vergangenheit war er Principal bei CVS, Inc. (Maryland), Vice President-Business Development & Strategy bei Celgene Corp., Principal bei Pfizer (St. Louis), Principal bei Brooks Eckerd Pharmacy, Research Analyst bei Barclays Capital, Inc. und Research Analyst bei Barclays Capital Securities Ltd. Er erhielt einen Undergraduate-Abschluss von der University of Pittsburgh und einen MBA von der Kelley School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2026 | 115 416 ( 0,08 % ) | 2 Mio $ | 31.05.2026 |
Aktive Positionen von Edward Dulac
| Unternehmen | Position | Beginn |
|---|---|---|
| INTELLIA THERAPEUTICS, INC. | Finanzdirektor/CFO | 22.07.2024 |
Ehemalige bekannte Positionen von Edward Dulac
| Unternehmen | Position | Ende |
|---|---|---|
| FATE THERAPEUTICS, INC. | Finanzdirektor/CFO | 14.06.2024 |
| CELGENE | Corporate Officer/Principal | 01.02.2020 |
Barclays Capital Securities Ltd.
 Barclays Capital Securities Ltd. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 25.07.2011 |
Pfizer (St. Louis)
 Pfizer (St. Louis) BiotechnologyHealth Technology Provides research services in prescription medicines for humans and animals | Corporate Officer/Principal | 30.11.2007 |
Brooks Eckerd Pharmacy | Corporate Officer/Principal | 30.06.2001 |
Ausbildung von Edward Dulac
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
84
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
University of Pittsburgh
 University of Pittsburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Barclays Capital, Inc.
 Barclays Capital, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Barclays Capital Securities Ltd.
Barclays Capital Securities Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Pfizer (St. Louis)
Pfizer (St. Louis) BiotechnologyHealth Technology Provides research services in prescription medicines for humans and animals | Health Technology |
Fate Therapeutics, Inc.
 Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Brooks Eckerd Pharmacy | |
CVS, Inc. (Maryland)
 CVS, Inc. (Maryland) Other Consumer ServicesConsumer Services Provides engineering, maintenance, and control programming services for video, audio, and control system | Consumer Services |
Kelley School of Business
 Kelley School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intellia Therapeutics, Inc.
 Intellia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel and potentially curative therapeutics | Health Technology |
